Free Trial

Jason Gerberry Analyst Performance

Equity Research at Bank of America

Jason Gerberry is a stock analyst at Bank of America in the medical sector, covering 33 publicly traded companies. Over the past year, Jason Gerberry has issued 26 stock ratings, including buy, hold, and sell recommendations. While full access to Jason Gerberry's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jason Gerberry's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
127 Last 10 Years
Buy Recommendations
70.40% 88 Buy Ratings
Companies Covered
33 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy70.4%88 ratings
Hold24.0%30 ratings
Sell5.6%7 ratings

Out of 125 total stock ratings issued by Jason Gerberry at Bank of America, the majority (70.4%) have been Buy recommendations, followed by 24.0% Hold and 5.6% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
75.8% of companies on NASDAQ
25 companies
NYSE
24.2% of companies on NYSE
8 companies

Jason Gerberry, an analyst at Bank of America, currently covers 33 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
33 companies
100.0%

Jason Gerberry of Bank of America specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
16 companies
48.5%
MED - DRUGS
6 companies
18.2%
LARGE CAP PHARMA
4 companies
12.1%
MED - GENERIC DRG
2 companies
6.1%
PHARMACEUTICAL PREPARATIONS
2 companies
6.1%
MEDICAL SERVICES
1 company
3.0%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC
1 company
3.0%
MED PRODUCTS
1 company
3.0%

Jason Gerberry's Ratings History at Bank of America

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
5/1/2026Lower Price Target$965.19$1,133.00Buy
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
4/9/2026Boost Price Target$30.77$42.00Buy
Pfizer Inc. stock logo
PFE
Pfizer
4/9/2026Lower Price Target$27.39$26.00Neutral
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
4/9/2026Boost Price Target$76.12$111.00Buy
Alkermes plc stock logo
ALKS
Alkermes
4/9/2026Boost Price Target$34.90$36.00Neutral
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
4/2/2026Boost Price Target$955.45$1,294.00Buy
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
3/25/2026Lower Price Target$9.03$29.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
2/25/2026Boost Price Target$173.83$275.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
2/25/2026Lower Price Target$28.19$28.00Underperform
Alkermes plc stock logo
ALKS
Alkermes
2/20/2026Boost Price Target$32.00$34.00Neutral
Pfizer Inc. stock logo
PFE
Pfizer
12/15/2025Lower Price Target$25.86$28.00Neutral
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
12/9/2025Boost Price Target$69.57$81.00Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
12/9/2025Boost Price Target$79.56$97.00Buy
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
12/9/2025Boost Price Target$28.60$32.00Buy
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
12/1/2025Boost Price Target$55.43$62.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
11/18/2025Boost Price Target$170.09$247.00Buy
Oculis Holding AG stock logo
OCS
Oculis
11/13/2025Lower Price Target$19.25$29.00Buy
Biohaven Ltd. stock logo
BHVN
Biohaven
11/5/2025Downgrade$8.10$10.00Neutral
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
9/23/2025Boost Price Target$61.36$83.00Buy
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
8/26/2025Boost Price Target$30.54$32.00Neutral
Immunovant, Inc. stock logo
IMVT
Immunovant
8/12/2025Lower Price Target$14.76$30.00Buy
Biohaven Ltd. stock logo
BHVN
Biohaven
8/12/2025Lower Price Target$13.42$49.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
8/5/2025Boost Price Target$102.86$176.00Buy
ProKidney Corp. stock logo
PROK
ProKidney
6/30/2025Downgrade$0.67$1.00Underperform
Liquidia Corporation stock logo
LQDA
Liquidia
6/11/2025Lower Price Target$14.34$23.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
6/5/2025Boost Price Target$42.55$46.00Neutral
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
5/8/2025Boost Price Target$18.08$22.00Buy
Vaxcyte, Inc. stock logo
PCVX
Vaxcyte
4/1/2025Lower Price Target$36.81$137.00Buy
Immunovant, Inc. stock logo
IMVT
Immunovant
3/20/2025Lower Price Target$18.88$33.00Buy
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
3/6/2025Lower Price Target$15.59$20.00Buy
Viatris Inc. stock logo
VTRS
Viatris
2/28/2025Lower Price Target$9.53$10.00Underperform
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
2/11/2025Boost Price Target$133.41$167.00Buy
Immunovant, Inc. stock logo
IMVT
Immunovant
1/15/2025Lower Price Target$22.88$45.00Buy